40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
86.64%
Revenue growth exceeding 1.5x CRK's 28.21%. David Dodd would verify if faster growth reflects superior business model.
6.97%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
224.24%
Gross profit growth exceeding 1.5x CRK's 55.36%. David Dodd would verify competitive advantages.
73.72%
Margin expansion exceeding 1.5x CRK's 21.18%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
3.79%
G&A growth less than half of CRK's 36.50%. David Dodd would verify if efficiency advantage is structural.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.38%
Operating expenses growth less than half of CRK's 36.50%. David Dodd would verify sustainability.
6.39%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
-7.62%
Both companies reducing D&A. Martin Whitman would check industry patterns.
464.29%
EBITDA growth 50-75% of CRK's 805.17%. Martin Whitman would scrutinize operations.
198.59%
EBITDA margin growth exceeding 1.5x CRK's 4.81%. David Dodd would verify competitive advantages.
23983.33%
Operating income growth exceeding 1.5x CRK's 1.03%. David Dodd would verify competitive advantages.
12803.59%
Operating margin growth while CRK declines. John Neff would investigate advantages.
18.18%
Other expenses growth less than half of CRK's 126.28%. David Dodd would verify if advantage is sustainable.
2046.48%
Pre-tax income growth exceeding 1.5x CRK's 268.72%. David Dodd would verify competitive advantages.
1142.90%
Pre-tax margin growth exceeding 1.5x CRK's 231.60%. David Dodd would verify competitive advantages.
-300.00%
Tax expense reduction while CRK shows 256.90% growth. Joel Greenblatt would examine advantage.
2022.22%
Net income growth exceeding 1.5x CRK's 223.48%. David Dodd would verify competitive advantages.
1129.91%
Net margin growth exceeding 1.5x CRK's 196.31%. David Dodd would verify competitive advantages.
1992.86%
EPS growth exceeding 1.5x CRK's 223.39%. David Dodd would verify competitive advantages.
1992.86%
Diluted EPS growth exceeding 1.5x CRK's 204.84%. David Dodd would verify competitive advantages.
0.92%
Share count reduction below 50% of CRK's 0.10%. Michael Burry would check for concerns.
No Data
No Data available this quarter, please select a different quarter.